Remyelination Trials
Are We Expecting the Unexpected?
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received March 20, 2021
- Accepted in final form June 14, 2021
- First Published August 10, 2021.
Author Disclosures
- Alexandr Klistorner, PhD and
- Michael Barnett, PhD (michael{at}snac.com.au)
- Alexandr Klistorner, PhD and
NONE
NONE
NONE
NONE
1. "Electrophysiological visual field measurement" Klistorner and Graham 1999, PCT/AU99/00340 2. "Method and apparatus for objective electrophysiological assessment of visual function" Klistorner and Graham 2001, PCT/AU01/00423 3. ?Stimulus Method for Multifocal Visual Evoked Potential? Klistorner and Graham (Australian Patent Application No 2007900803) 4. ?Flexible electrode assembly and apparatus for measuring electrophysiological signals? Cheng, Klistorner, Graham (Australian Provisional Patent # 2006904755) 5. ?Apparatus for measuring electrophysiological signals? Cheng, Klistorner, Dyer - Australian Design No. 310666. 6. ? Flexible printed circuit board electrode assembly? Cheng, Klistorner, Dyer - Australian Design No. 311943.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1. Sydney University Foundation for Medical Research 2. Sydney eye hospital foundation 3. National MS Society
NONE
NONE
NONE
NONE
NONE
NONE
- Michael Barnett, PhD (michael{at}snac.com.au)
NONE
NONE
(1) Alexion, Speaker honoraria (2) Novartis, Speaker honoraria (3) Biogen, Speaker honoraria (4) Roche, Speaker honoraria
NONE
NONE
NONE
NONE
(1) RxMx (2) Sydney Neuroimaging Analysis Centre
NONE
NONE
NONE
(1) Sanofi-Genzyme (2) Bristol Myers Squibb (3) Roche (4) Novartis (5) Biogen (6) Merck
(1) Australian Government, MRFF Grant, 2021-2024, PI (2) Australian Government, CRC Grant, 2018-2021, PI
(1) University of Sydney (2) Sydney Neuroimaging Analysis Centre (3) Royal Prince Alfred Hospital Stock/Stock Options, Medical Equipment & Materials: (1) RxMx (stock), 2015-
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Sydney University (A.K., M.B.); Maquarie University (A.K.); and Sydney Neuroimaging Analysis Center (M.B.), Australia.
- Correspondence
Dr. Klistorner sasha{at}eye.usyd.edu.au
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
Optical coherence tomography and disease subtype in multiple sclerosisM. Pulicken, E. Gordon-Lipkin, L. J. Balcer et al.Neurology, November 26, 2007 -
Article
Chronic demyelination exacerbates neuroaxonal loss in patients with MS with unilateral optic neuritisYuyi You, Michael H. Barnett, Con Yiannikas et al.Neurology: Neuroimmunology & Neuroinflammation, March 13, 2020 -
Articles
Diagnostic accuracy of retinal abnormalities in predicting disease activity in MSJorge Sepulcre, Manuel Murie-Fernandez, Angel Salinas-Alaman et al.Neurology, April 30, 2007 -
Article
No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in MSMarco Pisa, Simone Guerrieri, Giovanni Di Maggio et al.Neurology, November 15, 2017